Treatment Details - 8.8 months - Surviving Mesothelioma

Treatment Details – 8.8 months

Survival: 8.8 months
   
Toxicity Grade: 4
   
Treatments: Chemotherapy
   
Drugs: Vepesid
Country: Netherlands
   
City/State/Province: Amsterdam
   
Hospital: University Hospital Vrije Universiteit
   
Journal: Link
   
Date: 11/1997

Description:
Patients: This Phase II trial involved 41 patients with malignant pleural mesothelioma.

Treatment: The treatment consisted of a chemotherapy drug, oral etoposide (VP 16-213, vepesid).

Toxicity: Grade 3-4 toxicities included hematological, nausea/vomiting, cutaneous reaction, and alopecia.

Results: Median survival was 38 weeks (8.8 months).

Get your free copy of
Surviving Mesothelioma Today!